Original language | English (US) |
---|---|
Pages (from-to) | 825-827 |
Number of pages | 3 |
Journal | JAMA - Journal of the American Medical Association |
Volume | 319 |
Issue number | 8 |
DOIs | |
State | Published - Feb 27 2018 |
ASJC Scopus subject areas
- Medicine(all)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Trends in red blood cell, plasma, and platelet transfusions in the United States, 1993-2014. / Goel, Ruchika; Chappidi, Meera R.; Patel, Eshan U. et al.
In: JAMA - Journal of the American Medical Association, Vol. 319, No. 8, 27.02.2018, p. 825-827.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Trends in red blood cell, plasma, and platelet transfusions in the United States, 1993-2014
AU - Goel, Ruchika
AU - Chappidi, Meera R.
AU - Patel, Eshan U.
AU - Ness, Paul M.
AU - Cushing, Melissa M.
AU - Frank, Steven M.
AU - Tobian, Aaron A.R.
N1 - Funding Information: Accepted for Publication: December 1, 2017. Corresponding Author: Aaron Tobian, MD, PhD, Department of Pathology, Johns Hopkins University, Carnegie 437, 600 N Wolfe St, Baltimore, MD 21287 (atobian1@jhmi.edu). Author Contributions: Drs Goel and Tobian had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Goel, Chappidi, Patel, Ness, Frank, Tobian. Acquisition, analysis, or interpretation of data: Goel, Chappidi, Patel, Cushing, Frank, Tobian. Drafting of the manuscript: Goel, Chappidi, Patel, Tobian. Critical revision of the manuscript for important intellectual content: Goel, Chappidi, Patel, Ness, Cushing, Frank. Statistical analysis: Goel, Chappidi, Patel. Obtained funding: Tobian. Administrative, technical, or material support: Ness, Frank, Tobian. Supervision: Ness, Tobian. Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Ness reported receiving personal fees from Terumo BCT and Haemonetics. Dr Cushing reported receiving personal fees from Octapharma. No other disclosures were reported. Funding/Support: This work was supported in part by grants NIH 5R01AI120938-02 and 1R01AI128779-01 from the National Institutes of Health (Dr Tobian) and from Weill Cornell Medical College (Dr Goel).
PY - 2018/2/27
Y1 - 2018/2/27
UR - http://www.scopus.com/inward/record.url?scp=85042593997&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042593997&partnerID=8YFLogxK
U2 - 10.1001/jama.2017.20121
DO - 10.1001/jama.2017.20121
M3 - Letter
C2 - 29486023
AN - SCOPUS:85042593997
SN - 0098-7484
VL - 319
SP - 825
EP - 827
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 8
ER -